MSB vs NTI

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

41LOW

NTI

NEUROTECH FPO [NTI]

51MEDIUM

Score Breakdown

MSB NTI
Technical
35
61
Catalyst
53
53
Sentiment
50
50
Fundamental
80
72
Momentum
60
56
Risk Gate
40
31

Key Metrics

MSB Metric NTI
$3.1BMarket Cap$23.7M
4.1MAvg Volume (20d)2.5M
+7.8%Short InterestN/A
$3.31052-Week High$0.029
$1.88052-Week Low$0.010
-4.5%Daily Change-5.6%
$2.320Reference Price$0.017
-18.2%ROE-66.3%
-144.3%Profit Margin-54.4%

Active Signals

MSB Signals

●Above-average volume (1.6x) on a red day — sellers in control
●Took a hit — down 10.4% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Strong revenue growth (+1527%)
●EPS estimates revised upward (+10pts)
●Director buying detected (1 transactions)
●Elevated short interest (7.8%)

NTI Signals

●Trading above both moving averages — the trend is your friend here
●Above-average volume (1.7x) on a red day — sellers in control
●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)
●Low P/S ratio (3.4x)
●Strong revenue growth (+4069%)
●Small-cap ($20-100M)

Ask Scout AI to compare MSB and NTI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MSB vs NUZ →MSB vs ONE →MSB vs PEB →MSB vs PKP →MSB vs PKY →
MSB Full Analysis → NTI Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).